Universidad y ética profesional

by Juan Manuel COBO SUERO
Published 2009-11-01

La educación para la ciudadanía en España desde la LODE y la LOGSE al Anteproyecto de LOE. Algunas propuestas para la programación y los profesores

by Juan Manuel Cobo Suero
Published 2019-07-01

Prevalencia y severidad de la disfunción intestinal inducida por opioides

by Rafael Gálvez, Mariano Provencio, Manuel Cobo, Cristina Pérez, Concha Pérez, Jaume Canal
Published 2014-01-01

Anexo

by Luis Almenar, Javier Segovia, María G. Crespo-Leiro, Jesús Palomo, José M. Arizón, Manuel Cobo, Juan Delgado
Published 2011-01-01

Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade Response

by Qingyang Xiao, André Nobre, Pilar Piñeiro, Miguel-Ángel Berciano-Guerrero, Emilio Alba, Manuel Cobo, Volker M. Lauschke, Isabel Barragán
Published 2020-01-01

Hospitalisation Cost of Patients with Diabetic Foot Ulcers in Valencia (Spain) in the Period 2009–2013: A Retrospective Descriptive Analysis

by Pilar Nieto-Gil, Ana Belen Ortega-Avila, Manuel Pardo-Rios, Manuel Cobo-Najar, Carlos Blasco-Garcia, Gabriel Gijon-Nogueron
Published 2018-08-01

Androgens contribute to sex differences in myocardial remodeling under pressure overload by a mechanism involving TGF-β.

by Cecilia Montalvo, Ana V Villar, David Merino, Raquel García, Miguel Ares, Miguel Llano, Manuel Cobo, María A Hurlé, J Francisco Nistal
Published 2012-01-01

Plasma levels of transforming growth factor-beta1 reflect left ventricular remodeling in aortic stenosis.

by Ana V Villar, Manuel Cobo, Miguel Llano, Cecilia Montalvo, Francisco González-Vílchez, Rafael Martín-Durán, María A Hurlé, J Francisco Nistal
Published 2009-12-01

Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database

by Begoña Campos‐Balea, Javier deCastro Carpeño, Bartomeu Massutí, David Vicente‐Baz, Diego Pérez Parente, Pedro Ruiz‐Gracia, Leonardo Crama, Manuel Cobo Dols
Published 2020-11-01

Revisión de la publicación de la información obligatoria en detergentes del Distrito Sanitario Jaén Sur

by María del Carmen Casañas Carrillo, Gonzalo Hurtado Bejarano, Dolores De la Rosa Millán, Mª Jesús Ollero Palma, Francisco Perales Godoy, Manuel Cobo Aceituno
Published 2015-05-01

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial

by Glenwood D. Goss, Manuel Cobo, Shun Lu, Konstantinos Syrigos, Ki Hyeong Lee, Erdem Göker, Vassilis Georgoulias, Dolores Isla, Alessandro Morabito, Young J. Min, Andrea Ardizzoni, Shaun Bender, Agnieszka Cseh, Enriqueta Felip
Published 2021-07-01

PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis

by Margarita Majem, Manuel Cobo, Dolores Isla, Diego Marquez-Medina, Delvys Rodriguez-Abreu, Joaquín Casal-Rubio, Teresa Moran Bueno, Reyes Bernabé-Caro, Diego Pérez Parente, Pedro Ruiz-Gracia, Marta Marina Arroyo, Luis Paz-Ares
Published 2021-03-01

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)

by Daniel Morgensztern, Manuel Cobo Dols, Santiago Ponce Aix, Pieter E. Postmus, Jaafar Bennouna, Jürgen R. Fischer, Oscar Juan-Vidal, David J. Stewart, Andrea Ardizzoni, Rafia Bhore, Marianne Wolfsteiner, Martin Reck, Denis Talbot, Ramaswamy Govindan, Teng Jin Ong
Published 2021-02-01

Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study

by Sofía Ruiz-Medina, Silvia Gil, Begoña Jimenez, Pablo Rodriguez-Brazzarola, Tamara Diaz-Redondo, Mireya Cazorla, Marta Muñoz-Ayllon, Inmaculada Ramos, Carmen Reyna, María José Bermejo, Ana Godoy, Esperanza Torres, Manuel Cobo, Laura Galvez, Antonio Rueda, Emilio Alba, Nuria Ribelles
Published 2021-06-01

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

by Jean-Charles Soria, Enriqueta Felip, Manuel Cobo, Shun Lu, Konstantinos Syrigos, Ki Hyeong Lee, Erdem Göker, Vassilis Georgoulias, Wei Li, Dolores Isla, Salih Z Guclu, Alessandro Morabito, Young J Min, Andrea Ardizzoni, Shirish M Gadgeel, Bushi Wang, Vikram K Chand, Glenwood D Goss
Published 2015-09-01

Lung cancer symptoms at diagnosis: results of a nationwide registry study

by Maria Sala, Ana Laura Ortega Granados, Virginia Calvo de Juan, Teresa Moran, Delvys Rodriguez-Abreu, Rafael López-Castro, Eugenio Cuadrado Albite, María Guirado, Lucía Gómez González, Ana Blasco, Manuel Cobo, Rosario Garcia-Campelo, Joaquim Bosch, José Trigo, Óscar Juan, Carlos Aguado de la Rosa, Manuel Dómine, Juana Oramas, Joaquín Casal-Rubio, Sara Cerezo
Published 2020-12-01

Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry.

by Fernando Franco, Enric Carcereny, Maria Guirado, Ana L Ortega, Rafael López-Castro, Delvys Rodríguez-Abreu, Rosario García-Campelo, Edel Del Barco, Oscar Juan, Francisco Aparisi, Jose L González-Larriba, Manuel Domine, Jose M Trigo, Manuel Cobo, Sara Cerezo, Julia Calzas, Bartomeu Massutí, Joaquim Bosch-Barrera, Paola García Coves, Marta Domènech, Mariano Provencio
Published 2021-01-01

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.

by Rafael Rosell, Laia Perez-Roca, Jose Javier Sanchez, Manuel Cobo, Teresa Moran, Imane Chaib, Mariano Provencio, Manuel Domine, Maria Angeles Sala, Ulpiano Jimenez, Pilar Diz, Isidoro Barneto, Jose Antonio Macias, Ramon de Las Peñas, Silvia Catot, Dolores Isla, Jose Miguel Sanchez, Rafael Ibeas, Guillermo Lopez-Vivanco, Juana Oramas, Pedro Mendez, Noemi Reguart, Remei Blanco, Miquel Taron
Published 2009-01-01

A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Th...

by Jonathan W. Goldman, Julien Mazieres, Fabrice Barlesi, Konstantin H. Dragnev, Marianna Koczywas, Tuncay Göskel, Alexis B. Cortot, Nicolas Girard, Claas Wesseler, Helge Bischoff, Ernest Nadal, Keunchil Park, Shun Lu, Alvaro Taus, Manuel Cobo, Shawn T. Estrem, Sameera R. Wijayawardana, Kellie Turner, Gerard Joseph Oakley, Karla C. Hurt, Alan Y. Chiang, Anwar M. Hossain, William J. John, Luis Paz-Ares
Published 2020-10-01

Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial

by Raquel Laza‐Briviesca, Alberto Cruz‐Bermúdez, Ernest Nadal, Amelia Insa, María del Rosario García‐Campelo, Gerardo Huidobro, Manuel Dómine, Margarita Majem, Delvys Rodríguez‐Abreu, Alex Martínez‐Martí, Javier De Castro Carpeño, Manuel Cobo, Guillermo López Vivanco, Edel Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Bartomeu Massuti, Marta Casarrubios, Belén Sierra‐Rodero, Carlos Tarín, Aránzazu García‐Grande, Cara Haymaker, Ignacio I. Wistuba, Atocha Romero, Fernando Franco, Mariano Provencio
Published 2021-07-01